Nasrin . Forghani

Dr. Nasrin . Forghani

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in Current Journal of Neurology
Verified
Journal Article
Open access
MHMazyar Hashemilar
Mazyar Hashemilar
APAfshin Partovi
Afshin Partovi
NFNasrin . Forghani
Nasrin . Forghani
ESEhsan Sharifipour
Ehsan Sharifipour
Background: Atherosclerotic involvement of large and small cerebral arteries leading to infarction is among the most prevalent subtypes of stroke worldwide. The hemodynamic changes due to these arterial pathologies can be studied non-invasively and in real-time by using transcranial Doppler (TCD) techniques. TCD indices of the studied arteries may guide the clinician in differentiating these two underlying arterial pathologies. Methods: A cross-sectional study of patients with small and large vessel types of cerebral infraction based on the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) stroke classification was undertaken in the inpatient population of neurology service of Razi Hospital, Tabriz, Iran, from October 2018 to October 2019. After clinical diagnosis, all cases underwent TCD studies, brain magnetic resonance imaging (MRI), and brain and cervical four-vessel magnetic resonance angiography (MRA). The results of TCD indices related to major arteries of the circle of Willis were tabulated and compared between large and small vessel subtypes of cerebral infarction. Results: A statistically significant difference between right middle cerebral artery (MCA) pulsatility index (PI), left MCA PI, right internal carotid artery (ICA) PI, end-diastolic velocity (EDV), left ICA PI, left ICA EDV, left anterior cerebral artery (ACA) PI, and right vertebral artery (VA) PI measures of the two groups was seen (P < 0.05). In comparison to the large vessel group, left ACA, right VA, and bilateral MCAs and ICAs in the small-vessel stroke group demonstrated an elevated PI. Conclusion: A significant increase of PI occurs in the majority of intracranial arteries of patients with small vessel stroke. This makes PI a valuable marker for differentiating strokes with different underlying pathophysiologies.

9 May 2026 in Biology
Verified
Journal Article
Open access
PDF file
RHReza Mosaddeghi Heris
Reza Mosaddeghi Heris
NFNasrin . Forghani
Nasrin . Forghani
NDNegin Safari Dehnavi
Negin Safari Dehnavi
MSMaryam Saberivand
Maryam Saberivand
ATAmir Tahavvori
Amir Tahavvori
PMPaolo Martelletti
Paolo Martelletti
Sensory neurons at barrier tissues were once seen as passive detectors of environmental stimuli. However, in the last five years, increasing evidence has challenged this view, redefining these cells as active immune sentinels that directly affect tissue immunity in the skin, lungs, and gastrointestinal tract. Nociceptors and pruriceptors express various immune-sensing receptors, including Toll-like receptors, cytokine receptors, and alarmin sensors, which allow them to directly detect pathogens, allergens, and tissue damage. When activated, sensory neurons quickly release neuropeptides such as calcitonin gene-related peptide (CGRP), substance P, vasoactive intestinal peptide (VIP), and PACAP (pituitary adenylate cyclase-activating polypeptide), which guide immune cell recruitment, activation, and resolution. Reciprocally, immune-derived mediators, including IL-33, IL-31, thymic stromal lymphopoietin (TSLP), IL-4/IL-13, and TNF-α, modulate neuronal excitability and plasticity, forming bidirectional neuroimmune circuits that control inflammation, host defense, pain, and itch. Landmark studies published in 2024–2025, including neuronal control of gut Treg function and the identification of sensory nerve immune niches, have further refined this framework and revealed tissue-specific circuit specialization. This review synthesizes recent insights from molecular, cellular, and systems levels into the sensory neuroimmune axis, emphasizes its protective versus pathogenic roles, and critically evaluates emerging therapeutic strategies and safety concerns, positioning sensory neuroimmunology as a unifying framework for tissue barrier homeostasis and disease.

1 January 2023 in International Journal of Drug Research in Clinics
Verified
Journal Article
Open access
PDF file
SHSamaneh Hosseini
Samaneh Hosseini
NFNasrin . Forghani
Nasrin . Forghani
SHSina Hassannezhad
Sina Hassannezhad
HKHanie Karimi
Hanie Karimi
RHReza Mosaddeghi Heris
Reza Mosaddeghi Heris
Background: Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, leading to inflammation and damage to the protective covering of nerve fibers. MS patients have an increased risk of developing epileptic seizures compared to the general population. The incidence of seizures in MS patients varies across different studies, ranging from 0.5% to 8.3%. Fingolimod is an oral medication used for the treatment of relapsing-remitting MS. It works by inhibiting sphingosine 1-phosphate receptors, which helps to reduce inflammation and prevent immune cells from attacking the nervous system. However, discontinuation of Fingolimod therapy can lead to withdrawal symptoms and potentially increase the risk of epileptic seizures in MS patients. Methods: In this case report, we aimed to present a rare manifestation of seizure as a rebound activity following discontinuation of Fingolimod therapy. We reviewed the existing literature to explore the association between Fingolimod and seizures in MS patients. Relevant studies and case reports were identified through a comprehensive search of electronic databases. Results: Our case report describes a patient who experienced a seizure after discontinuing Fingolimod therapy. This suggests that abrupt withdrawal of Fingolimod may trigger rebound activity, including seizures, in some MS patients. The literature review revealed several other cases reporting seizures or convulsions associated with Fingolimod use in MS patients. The incidence of seizures in these cases varied, highlighting the need for further research to determine the exact risk. Conclusion: Fingolimod discontinuation can lead to rebound activity, including seizures, in some MS patients. It is important for healthcare professionals to be aware of this potential risk and carefully manage the discontinuation process. Further research is needed to better understand the incidence and mechanisms underlying Fingolimod-associated seizures in MS patients.

Verified
Journal Article
Open access
PDF file
HSHadi Sahrai
Hadi Sahrai
RHReza Mosaddeghi Heris
Reza Mosaddeghi Heris
NFNasrin . Forghani
Nasrin . Forghani
ANAli Norouzi
Ali Norouzi
SZSahand Zare
Sahand Zare
MFmaryam farzaneh
maryam farzaneh
Malignant gliomas are highly aggressive primary brain tumors for which the therapeutic efficacy of cisplatin is frequently limited by intrinsic or acquired drug resistance. Despite advances in adjuvant therapies, overcoming chemoresistance remains a major challenge in the treatment of these malignancies. Emerging evidence indicates that long non-coding RNAs (lncRNAs), a class of non-protein-coding transcripts involved in gene regulation, play important roles in modulating treatment responses. Several lncRNAs, including differentiation antagonizing non-protein-coding RNA (DANCR), HOXD antisense growth-associated long non-coding RNA (HOXD-AS1), MEG3, MALAT1, and HOTAIR, have been implicated in pathways associated with glioma progression and therapeutic resistance. In particular, DANCR has been reported to promote cisplatin resistance in glioma cells through suppression of apoptosis and activation of pro-survival signaling pathways. This review summarizes current evidence regarding the roles of lncRNAs in cisplatin resistance, highlighting mechanisms such as regulation of drug transport, DNA damage repair, apoptosis, cancer stem-cell maintenance, and signaling pathways associated with treatment adaptation. We also discuss current limitations, challenges for clinical translation, and gaps in the existing evidence. A better understanding of lncRNA-mediated resistance mechanisms may facilitate the identification of novel therapeutic targets and inform future studies aimed at overcoming cisplatin resistance in malignant gliomas.

30 May 2021 in Archives of Neuroscience
Verified
Journal Article
Open access
PDF file
MHMazyar Hashemilar
Mazyar Hashemilar
NFNasrin . Forghani
Nasrin . Forghani
Context: Given its cerebral amyloid angiopathy, subarachnoid hemorrhage might represent transient focal neurological episodes erroneously diagnosed as transient ischemic attacks. The earliest neuroimaging findings in emergency room brain computed tomography indicating subarachnoid hemorrhage in these patients might be very subtle and missed by the clinician. Case Presentation: An 80-year-old man referred with transient focal neurological episodes, suggestive of transient ischemic attacks. In general, except for some cognitive dysfunctions, no remarkable point was noticed in his neurological examination. Non-enhanced brain-computer tomography and magnetic resonance imaging revealed evidence indicating slight convexity subarachnoid hemorrhage at the left frontal cortical region. Conclusions: The transient focal neurological episodes uncommonly represent intracranial hemorrhage. Nevertheless, this clinical representation might occur in patients with subarachnoid hemorrhage due to cerebral amyloid angiopathy. In such cases, the neuroimaging findings play a major role in the differential diagnosis. The misdiagnosis of transient ischemic attacks in these cases might lead to the consumption of antiplatelet drugs and end in catastrophic hemorrhage and life-threatening complications. Close attention to patients' clinical findings and judicious use of further neuroimaging studies would help clinicians to avoid making such mistakes.

27 February 2023 in Journal of Research in Clinical Medicine
Verified
Journal Article
Open access
PDF file
MYMohammad Yazdchi
Mohammad Yazdchi
RKRamin Khanalizadeh
Ramin Khanalizadeh
NFNasrin . Forghani
Nasrin . Forghani
ZJZahra Jalali
Zahra Jalali
MTMahnaz Talebi
Mahnaz Talebi
Fahr’s disease is a rare condition characterized by the symmetrical calcification of basal ganglia and dentate nuclei of the cerebellum calcification. It is usually manifested by involuntary movements and psychiatric symptoms. Ataxia has been reported as an uncommon manifestation of Fahr’s disease. Herein we introduce a 41-year-old man presenting with progressive gait disturbance who was finally diagnosed with Fahr’s disease.